Login
← Go Back
Alivus Life Sciences
ALIVUS · Pharma > Pharmaceuticals & Drugs · Chairman: Glenn Saldanha · MD: Yasir Rawjee · Listing date: Aug. 7, 2021 · Employees: 1537 · Mumbai · http://www.glenmarklifesciences.com
Stock Price vs Company Growth
1d
2.3%
1w
3.6%
1m
0.2%
3m
9.8%
6m
24.4%
1y
8.1%
all
11.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,104 2.3%
996
1,193
Company Overview
Sales
2,552 Cr
Growth: 7.1%
Profit after Tax
564 Cr
Growth: 3.8%
Mid Cap
13,555 Cr
P/E: 24.1x
Industry P/E: 32.3x
Fundamentals
Sales (Cr) ₹ 2,552
Growth 7.1%
EBITDA 31.2%
P/S 5.3x
Dividend 0.5%
P/E 24.1x
Book Value ₹ 271
PEG Ratio 3.5x
ROE 18.0%
P/B 4.2x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is in the business of making high-quality drugs by unlocking the possibilities of science.Awards, accreditations and recognitions2015: Ankleshwar plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Dahej plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Ankleshwar plant received BS OHSAS 18001:2017 certifying the management system of the manufacturing facility.
Belongs to (14 Indices) view more
Investors (7)
icici.pr...
societe....
nirma
Followers (2)
atharav
varsha96